Crosstalk between PI3K/AKT signaling and epigenetic regulation in hepatocellular carcinoma: molecular mechanisms and therapeutic opportunities
Hepatocellular carcinoma (HCC) is an aggressive malignancy, and most patients are diagnosed at intermediate or advanced stages. Targeted therapies, immunotherapies, and combination regimens have limited efficacy, creating a major clinical challenge. The phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway...